- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI Summary - About
Solventum Corp.(SOLV)
Advisory History & Simulated Performance *
*as per simulation (see disclosures)- ALL
- 1Y
- 1M
- 1W
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- PASS (Skip)
Advisory Performance History (Simulated)
Upturn Advisory & Investor View for SOLV
11/19/2026: SOLV (3-star) is currently NOT-A-BUY. Pass it for now.
Solventum Corp. is a global healthcare company specializing in medical-surgical supplies, dental solutions, and health information systems following its 2024 spin-off from 3M. The company's main strengths include trusted legacy brands, robust gross profit margins, and essential consumable product franchises like V.A.C.® Therapy. Its core investment narrative centers on portfolio optimization, margin enhancement, and selective bolt-on acquisitions in advanced wound care. However, key risks involve integration and separation friction, moderate organic growth rates, and hospital pricing pressures. Solventum suits value-oriented investors seeking defensive healthcare exposure while monitoring execution on strategic portfolio reviews.
How to Read the Upturn Advisory
The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.
Company fundamentals, valuation, risks, and news provide supporting context about the business.
Investor Fit
| Investor style | Fit | Why |
|---|---|---|
| Growth investor | Mixed fit | Solventum offers low-single-digit organic revenue growth, appealing more to turnaround or operational-improvement strategies than high-beta growth seekers. |
| Momentum investor | Mixed fit | Momentum fit depends on sustained positive breakouts following portfolio reshaping and clearer earnings predictability. |
| Value investor | Strong fit | The stock trades at reasonable earnings multiples relative to diversified healthcare peers as it executes its standalone transformation. |
| Dividend investor | Weak fit | The company currently prioritizes debt reduction and operational reinvestment over returning capital via robust dividends. |
| Low-risk investor | Mixed fit | While healthcare demand is defensive, post-spinoff execution risks and operational restructuring create moderate near-term volatility. |
Risk Profile
| Risk factor | Level | Why it matters |
|---|---|---|
| Price volatility | Medium | Post-spinoff restructuring and transition milestones can trigger short-term equity price fluctuations. |
| Valuation risk | Low | Current market valuations account for near-term headwinds and post-spin transition adjustments. |
| Competition risk (healthcare equipment and informatics competition) | Medium / high | Intense competition from established medtech leaders puts pressure on pricing and hospital contracts. |
| Business quality | Strong | The company features high gross margins and sticky, mission-critical healthcare consumable franchises. |
| Dividend income | Low / none | Income-focused investors will find limited immediate dividend yield as capital is retained for growth. |
| Execution risk | Medium / high | Successfully executing IT separation, ERP cutovers, and potential business divestitures is vital to margin goals. |
Key Highlights
Company Size Large-Cap Stock | Market Capitalization 14.70B USD | Price to earnings Ratio 97.17 | 1Y Target Price 98.38 |
Price to earnings Ratio 97.17 | 1Y Target Price 98.38 | ||
Volume (30-day avg) 1.2M shares | Beta 0.75 | 52 Weeks Range 62.38 - 94.16 | Updated Date 11/19/2026 |
52 Weeks Range 62.38 - 94.16 | Updated Date 11/19/2026 | ||
Dividends yield (FY) - | Basic EPS (TTM) 0.89 |
Sector & Industry Intelligence
Sector
Healthcare
Bullish- Sentiment
- Strong Bullish
- Momentum
- Momentum Steady
- BUY participation
- 61.0%
- Active BUY / eligible
- 64 / 105
- 30-Day BUY Count Change
- +16
- Market state
- Strong Bullish
The number of qualifying BUY stocks has remained relatively stable.
Industry
Medical Instruments & Supplies
- BUY participation
- 40.0%
- Active BUY / eligible
- 2 / 5
- 30-Day BUY Count Change
- 0
Eligible universe: 5 stocks.
Sector signal summarizes BUY breadth conditions for the sector. It does not override this stock’s BUY, SELL, or PASS advisory.
Price Behavior

Strong Uptrend
The stock has maintained a strong upward price trend across the last three quarters.

Smooth
The stock has moved along a generally orderly path with only modest fluctuations.
Analysis of Past Performance
Type Stock | Historic Profit 13.57% | Avg. Invested days 48 | Today’s Advisory PASS |
Upturn Advisory Rating ![]() | Upturn Advisory Performance | Stock Returns Performance |
Upturn Scorecard
Upturn Star Rating 
Company Fundamentals 
Financial Health Rating 
Growth Momentum Score 
Ownership 
Top 5 Institutional Investors
Unit Economics (Per $1K Revenue) 
Economic Dimensions
Quantitative Style Profile 
Style Classification
Quality Focused
How Company Makes Money
| Business area | What it includes | Retail investor read |
|---|---|---|
| MedSurg | Advanced wound care, infection prevention, surgical tapes, and patient monitoring products sold globally. | This is the company's largest revenue engine, providing steady, consumable-driven cash flows from hospitals. |
| Dental Solutions | Restorative composites, orthodontic brackets, aligners, and preventive dental consumables. | Provides steady exposure to dental practices and elective dental procedures. |
| Health Information Systems | Software solutions for clinical documentation, medical coding automation, and revenue cycle management. | Offers technology-driven recurring software revenue streams supporting hospital efficiency. |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date 2026-11-05 | When After Market | Estimate 1.35 | Actual 1.45 |
Profitability
Profit Margin 1.91% | Operating Margin (TTM) 5.91% |
Management Effectiveness
Return on Assets (TTM) 2.14% | Return on Equity (TTM) 3.19% |
Valuation
Trailing PE 97.17 | Forward PE 11.51 | Enterprise Value 19.43B | Price to Sales(TTM) 1.8 |
Enterprise Value 19.43B | Price to Sales(TTM) 1.8 | ||
Enterprise Value to Revenue 2.38 | Enterprise Value to EBITDA 20.76 | Shares Outstanding 169.96M | Shares Floating 143.61M |
Shares Outstanding 169.96M | Shares Floating 143.61M | ||
Percent Insiders 15.37 | Percent Institutions 76.88 |
Financial Metrics
🧭 Investment Snapshot
Total Revenue (Scale)
Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.
Net Income (Profit)
Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.
Free Cash Flow (Cash Strength)
Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.
📈 Growth & Strength
Operating Income (Core Profit)
Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.
EBITDA (Cash Earnings)
Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.
Gross Profit (Unit Profitability)
Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.
🛡️ Financial Safety
Cash (Liquidity Buffer)
Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.
Total Debt (Leverage Risk)
Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.
Net Working Capital (Short-Term Health)
Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.
🧱 Balance Sheet Strength
Stockholder Equity (Net Worth)
Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.
Total Assets (Asset Base)
The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.
Income Before Tax (Pre-Tax Earnings)
Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.
⚙️ Cost & Drag Factors
Cost of Revenue (Production Cost)
Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.
Total Operating Expenses (Operating Cost)
Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.
Income Tax Expense (Tax Drag)
Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
All company names, trademarks, logos, and brands are the property of their respective owners and are used for identification and informational purposes only. Use of these names, trademarks, and logos does not imply endorsement by their respective owners.

